Inventor · disambiguated record
Earl Albone
Also filed as: ALBONE EARL · ALBONE EARL F · ALBONE EARL FRANCIS
15 granted patents·9 pending applications·62 citations·filing 1997–2022
91Inventor score
Top patents by PatentIndex Score
24 records- 0192US11753669B2Lysine conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2021·Granted Sep 12, 2023·2 cites·27 claims
- 0292US10322192B2Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2018·Granted Jun 18, 2019·18 cites·11 claims
- 0390US11572414B2Eribulin antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2020·Granted Feb 7, 2023·2 cites·6 claims
- 0488US10548986B2Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2017·Granted Feb 4, 2020·9 cites·13 claims
- 0587US10941431B2Lysine conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2017·Granted Mar 9, 2021·3 cites·25 claims
- 0685US7429382B2Antibodies that bind cell-associated CA 125/O772P and methods of use thereofCORIXA CORP·Filed 2003·Granted Sep 30, 2008·17 cites·50 claims
- 0784US11135304B2C-terminal lysine conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2016·Granted Oct 5, 2021·2 cites·14 claims
- 0876US2023398228A1Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2022·Application pending·0 cites
- 0975US8124086B2Antibodies that bind cell-associated CA 125/O772P and methods of use thereofALBONE EARL F·Filed 2008·Granted Feb 28, 2012·2 cites·15 claims
- 1072US2020297860A1Eribulin-based antibody-drug conjugates and methods of useEISAI R&D MAN CO LTD·Filed 2019·Application pending·0 cites
- 1170US11129904B2Cys80 conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2019·Granted Sep 28, 2021·0 cites·7 claims
- 1270US8299230B2Nucleic acid molecules encoding antibodies that bind cell-associated CA 125/O772PALBONE EARL F·Filed 2012·Granted Oct 30, 2012·1 cites·2 claims
- 1368US2023001004A1Cys80 conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2021·Application pending·0 cites
- 1466US9676866B2Antibodies that bind cell-associated CA 125/O772PPURDUE PHARMA LP·Filed 2014·Granted Jun 13, 2017·0 cites·15 claims
- 1565US12214050B2C-terminal lysine conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2021·Granted Feb 4, 2025·0 cites·13 claims
- 1665US2019106508A1Antibodies that bind cell-associated ca 125/o772pPURDUE PHARMA LP·Filed 2018·Application pending·0 cites
- 1761US2018105601A1Antibodies That Bind Cell-Associated CA 125/O772PPURDUE PHARMA LP·Filed 2017·Application pending·0 cites
- 1859US2013281673A1Antibodies that bind cell-associated ca 125/o772pPURDUE PHARMA LP·Filed 2012·Application pending·0 cites
- 1953US10273310B2CYS80 conjugated immunoglobulinsEISAI R&D MAN CO LTD·Filed 2016·Granted Apr 30, 2019·0 cites·15 claims
- 2047US2003091580A1Compositions and methods for the therapy and diagnosis of ovarian cancerFiled 2001·Application pending·0 cites
- 2142US6107473AKringle-related clone HTHBZ47SMITHKLINE BEECHAM CORP·Filed 1998·Granted Aug 22, 2000·4 cites·9 claims
- 2242US2009226367A1Compositions comprising an anti-ca125 antibody and a cytotoxic compound and their use for the treatment of cancerEURO CELTIQUE SA·Filed 2006·Application pending·0 cites
- 2338US2001011077A1Secreted cysteine rich protein-6 (SCRP-6); polynucleotides and processes for producing polypeptidesFiled 2000·Application pending·0 cites
- 2437US6090579AHuman SDR2 cDNA cloneSMITHKLINE BEECHAM CORP·Filed 1997·Granted Jul 18, 2000·2 cites·11 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →